Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells.

Autor: Eberl, H. Christian1 hans-christian.h.eberl@gsk.com, Werner, Thilo1, Reinhard, Friedrich B.1, Lehmann, Stephanie1, Thomson, Douglas1, Chen, Peiling2, Zhang, Cunyu2, Rau, Christina1, Muelbaier, Marcel1, Drewes, Gerard1, Drewry, David3,4, Bantscheff, Marcus1 marcus.x.bantscheff@gsk.com
Zdroj: Scientific Reports. 10/2/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje